Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Pfizer Inc (PFE)
Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 163,237,792
  • Shares Outstanding, K 5,646,413
  • Annual Sales, $ 100,330 M
  • Annual Income, $ 31,372 M
  • 60-Month Beta 0.61
  • Price/Sales 1.63
  • Price/Cash Flow 3.79
  • Price/Book 1.68
Trade PFE with:

Options Overview Details

View History
  • Implied Volatility 25.05% ( +1.39%)
  • Historical Volatility 28.19%
  • IV Percentile 69%
  • IV Rank 43.21%
  • IV High 33.73% on 10/27/23
  • IV Low 18.44% on 06/09/23
  • Put/Call Vol Ratio 0.99
  • Today's Volume 147,489
  • Volume Avg (30-Day) 146,072
  • Put/Call OI Ratio 0.83
  • Today's Open Interest 2,242,104
  • Open Int (30-Day) 2,086,578

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate -0.16
  • Number of Estimates 6
  • High Estimate -0.10
  • Low Estimate -0.22
  • Prior Year 1.14
  • Growth Rate Est. (year over year) -114.04%

Price Performance

See More
Period Period Low Period High Performance
1-Month
28.30 +3.46%
on 12/01/23
31.41 -6.78%
on 11/06/23
-1.98 (-6.33%)
since 11/03/23
3-Month
28.30 +3.46%
on 12/01/23
36.29 -19.32%
on 09/05/23
-6.50 (-18.17%)
since 09/01/23
52-Week
28.30 +3.46%
on 12/01/23
54.93 -46.70%
on 12/14/22
-21.63 (-42.49%)
since 12/02/22

Most Recent Stories

More News
LITFULO™ Receives Health Canada Approval, Becoming the First Approved Treatment for Severe Alopecia Areata in Canada.

/CNW/ - Today, Pfizer Canada announced that Health Canada has granted a Notice of Compliance (NOC) for LITFULO™ (ritlecitinib). A once-daily oral treatment,...

PFE : 29.28 (+1.28%)
Roche's Bold Move into Obesity Treatment with $2.7B Carmot Therapeutics Takeover

Swiss pharmaceutical giant Roche (ROG) has marked a significant strategic shift by acquiring Carmot Therapeutics (CRMO), an obesity drug developer, for an upfront payment of $2.7 billion. This move positions...

ROG : 132.50 (+0.86%)
LLY : 585.68 (+0.28%)
AZN : 65.02 (+0.35%)
PFE : 29.28 (+1.28%)
ROIV : 9.94 (+0.91%)
Is Pfizer Stock a Buy Now?

Pfizer shares have fallen by double digits this year.

PFE : 29.28 (+1.28%)
Why I'm Considering Selling Pfizer for Tax-Loss Harvesting Purposes

For growth investors, it may be time to sell this pharma stock for tax-loss harvesting purposes.

PFE : 29.28 (+1.28%)
Everyone Is Talking About This Stock. Is It a Good Long-Term Option?

This company famously helps manage a prevalent chronic illness.

LLY : 585.68 (+0.28%)
PFE : 29.28 (+1.28%)
NVO : 100.92 (+0.52%)
An Important History Lesson for Gene-Editing Investors

Gene editing holds tremendous promise for patients and investors alike. But the road to success won't be easy.

NVO : 100.92 (+0.52%)
LLY : 585.68 (+0.28%)
PFE : 29.28 (+1.28%)
RHHBY : 35.4200 (+3.08%)
CRSP : 71.51 (+4.17%)
5 Top Stocks to Buy Before 2024

These stocks have room to run -- next year and over the long term.

CRSP : 71.51 (+4.17%)
LLY : 585.68 (+0.28%)
VRTX : 350.63 (-0.15%)
ISRG : 311.84 (-1.07%)
PFE : 29.28 (+1.28%)
Stock market today: Wall Street extends its rally and closes at highest level since March 2022

Stocks gained ground on Wall Street as the market comes off its best month in more than a year

PFE : 29.28 (+1.28%)
GOOGL : 129.27 (-1.96%)
DELL : 69.32 (-3.63%)
$SPX : 4,569.78 (-0.54%)
$DOWI : 36,204.44 (-0.11%)
$IUXX : 15,839.67 (-0.99%)
Dell, Marvell Technology fall; Ulta Beauty, UiPath rise, Friday, 12/1/2023

Stocks that traded heavily or had substantial price changes on Friday: Dell, Marvell Technology fall; Ulta Beauty, UiPath rise

GCO : 32.58 (+3.89%)
TLYS : 7.86 (-3.68%)
DELL : 69.32 (-3.63%)
ESTC : 110.51 (+0.28%)
PFE : 29.28 (+1.28%)
Why Pfizer Stock Is Sinking Today

The big drugmaker delivered bad news for its top pipeline program.

PFE : 29.28 (+1.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Pfizer Inc. is a research-based, global biopharmaceutical company. The company boasts a sustainable pipeline with multiple late-stage programs that can drive growth. Pfizer markets a wide range of drugs and vaccines. Its business comprises six business units - Oncology, Inflammation & Immunology, Rare...

See More

Key Turning Points

3rd Resistance Point 30.23
2nd Resistance Point 29.93
1st Resistance Point 29.61
Last Price 29.28
1st Support Level 28.99
2nd Support Level 28.69
3rd Support Level 28.37

See More

52-Week High 54.93
Fibonacci 61.8% 44.76
Fibonacci 50% 41.61
Fibonacci 38.2% 38.47
Last Price 29.28
52-Week Low 28.30

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar